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INTRODUCTION 
Hypothyroidism is one of the common occurrence of 
endocrine disorders in India [1]. Hypothyroidism  is  a  
clinical  event  resulting  from  the deficiency  of  thy-
roid  hormones  or   rarely  from their  impaired  activity  
at  the  tissue  level. Cholinesterase represents a group 
of enzymes that hydrolyze acetylcholine and other cho-
line esters. There are two main types of cholinesterase 
with different biochemical properties: true or specific 
cholinesterase or acetyl cholinesterase found in all ex-
citable tissues (central and peripheral nervous system 
and muscles) and in erythrocytes. It is a high-turnover 
enzyme with high affinity for acetylcholine, inhibited at 
high concentrations of acetylcholine, and with low 
affinity for non-cholineesters. The other one is the non-
specific or pseudocholinesterase or butyrylcholinester-
ase which hydrolyses both choline and aliphatic esters. 
PCHE is a α glycoprotein found in the central and pe-
ripheral nervous system, in most tissues, and in the 
liver [2]. PCHE is synthesized in liver and its serum ac-
tivity is influenced by liver disease. PCHE level in serum 
is a useful test of liver function [3]. Patients with myx-
oedema, the pathologically increased levels of serum 
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cholesterol (TC) and beta-lipoproteins were associated 
with diminished serum PCHE activity.  The  percentage  
of  the  pre-beta fraction was found to be increased in 
both hypo -  and hyperthyroid patients,  but  mecha-
nisms  leading  to  this  change  are  probably different  
in  the  two  pathological  conditions.  The behaviour of 
TC and PCHE activity and especially the ratio between 
these parameters might be used for the diagnosis of 
thyroid disease and for the control of therapeutic effi-
ciency [4]. The purpose of this study was to evaluate 
the serum level of PCHE in hypothyroid patients. 
MATERIALS AND METHODS 
Study design: Case control observational study. 
Ethics approval: Ethics approval by obtained from our 
institute JLN Medical College, Ajmer and informed con-
sent was taken from the participants.  
Study location: Patients attending the Medical OPD 
and Laboratory of the Biochemistry Department of JLN 
Medical College & Hospitals, Ajmer. 
Study period: 2015-2018. 
Sample size: 200 volunteers participated (Case =100, 
Control =100). 
Sampling method: Consecutive sampling method was 
used.  
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Inclusion criteria: The present study was conducted on 
100 newly diagnosed hypothyroid patients. The diag-
nose of hypothyroidism was established, based on the 
clinical signs and symptoms and the T3, T4 and TSH 
estimations (American Thyroid Association). For control 
group age and sex matched healthy volunteers were 
selected. 
Exclusion criteria: Patients on treatment for any thy-
roid disorder, liver disease, lipid lowering drugs, diabe-
tes, malignancy and pregnant women were excluded. 
Grouping: Group 1: Hypothyroid Group 2 : Control  
Methodology: From every participant questionnaire 
was given to find out the relevant information. Anthro-
pometric assessment was done and BMI was calculated 
[6]. Blood pressure was measured after 10 minutes of 
rest as routine examination. 3ml of blood sample was 
collected aseptically, serum was separated and  used 
for estimation of thyroid profile [7-9] and Pseudo-
cholinesterase [10] were done by using a ELISA method 
and serum cholesterol was done by enzymatic CHOD-
POD, end point method [11].  
Statistical analysis: Data (parameters) were presented 
as mean ± standard deviation. Level of statistical signifi-
cance was set at p<0.05. 
RESULTS 
Table 1. Comparison of thyroid parameters & PCHE in 
both study groups. 
 
Note:   p > 0.05 =  Not significant (NS) ; * p < 0.05 = 
Significant;  **p < 0.001 = Highly significant (HS). 
Table 2. Pearson correlation of PCHE (U/ml) with     
thyroid parameters. 
 
The Mean ± SD levels of T3, T4 and PCHE were lower in 
Parame-
ters 
  
Healthy  
Controls 
(Mean  
± S.D.) 
Hypothyroid 
Patients 
(Mean ± S.D.) 
p-  
value 
Total T3 
(ng/ml) 
1.15 ± 0.36 0.41 ± 0.20 0.0001
** 
Total T4 
(µg/dl) 
7.63 ± 1.59 2.67 ± 1.25 0.0001
** 
TSH  
(µIU/ml) 
2.91 ± 1.25 31.01 ± 8.18 0.0001
** 
PCHE (U/L) 6760.21±94
4.82 
3180.10±707.86 0.001*
* 
TC (mg/dl) 
188.70±12.2
9 
250.74±16.66 
0.0001
** 
Hypothyroid Patients 
Parameters Pearson  
correlation ( r ) 
P- Value 
PCHE vs T3 0.1973 p < 0.001 
PCHE vs T4 0.0217 p < 0.001 
PCHE vs TSH -0.1302  0.095 
hypothyroid patients, even with elevated serum TSH & 
cholesterol levels as compared to controls. Serum thy-
roid profile. TC and PCHE were observed statistically 
highly significant (p < 0.0001**) in hypothyroid patients 
when compared with euthyroid subjects (Table 1). Ta-
ble :2 shows a highly significant positive correlation 
between PCHE with total T3 & T4 ( p < 0.001) in hypo-
thyroid cases. The correlation between PCHE and TSH is 
negative. Due to decrease in T4 levels there is increase 
in TSH secretion in hypothyroid cases. 
DISCUSSION 
Hypothyroidism is a condition characterized by abnor-
mally low thyroid hormone production. There are many 
disorders that result in hypothyroidism. These disor-
ders may directly or indirectly involve the thyroid 
gland. Because thyroid hormone affects growth, devel-
opment, and many cellular processes, inadequate thy-
roid hormone has widespread consequences for the 
body. The results of the present study were found simi-
lar to Sleeba S K et [5], Thompson J.C et al [12] and 
Vlaicu R et al [4]. Vlaicu R et al [4]showed that de-
creased levels of Serum cholesterol and beta-
lipoproteins occurring in hyperthyroidism were found 
to be accompanied by an enhanced activity of pseudo-
cholinesterase, while in patients with myxedema, the 
pathologically increased levels of serum cholesterol 
and beta-lipoproteins were associated with diminished 
serum pseudocholinesterase activity. The behaviour of 
cholesterol and pseudocholinesterase activity and es-
pecially the ratio between these parameters might be 
used for the diagnosis of thyroid disease and for the 
control of therapeutic efficiency. In the present study 
we estimated pseudocholinesterase as diagnostic and 
prognostic marker for hypothyroid cases. Pseudo-
cholinesterase was found to be a diagnostic marker in 
detecting new cases of hypothyroidism with Area un-
der ROC curve is 0.999, indicating a good marker with 
high sensitivity (100%) and high specificity (96.2%). 
Pseudocholinesterase is significantly less in cases not 
on treatment with F=78, P<0.001**, however the cases 
on treatment are more close to controls with P=0.18. 
Sleeba S K et (2013) found that Patients who were new-
ly diagnosed with hypothyroidism had a mean pseudo-
cholinesterase level of 3170.19U/l. Hypothyroid pa-
tients on treatment showed a mean pseudocholinester-
ase level of 6320.32 U/l.  Serum Pseudo cholinesterase 
showed a negative correlation (-0.374) with TSH in the 
hypothyroid patients on treatment. Pseudo cholines-
terase levels in hypothyroids on treatment are more 
close to controls with P=0.189. Conclusions: Serum 
pseudocholinesterase activity is decreased by about 
31.6 % in hypothyroidism. Pseudo cholinesterase was 
found to be a good biochemical marker for detecting 
new cases of hypothyroidism with a sensitivity of 100% 
and specificity of 96.2%.  Serum Pseudocholinesterase 
levels may be used as a biochemical marker for diagno-
sis and prognosis in hypothyroidism.  
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 CONCLUSION 
Serum Pseudocholinesterase is helpful as biomarker in 
screening test for hypothyroidism along with thyroid 
stimulating hormone. 
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